Volume 26, Issue 3 (Autumn- Special Issue on COVID-19 2020)                   IJPCP 2020, 26(3): 374-387 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadpour M, Ghorbani V, Moradi S, Khaki Z, Foroughi A A, Rezaei M R. Psychometric Properties of the Iranian Version of the Coronavirus Anxiety Scale. IJPCP 2020; 26 (3) :374-387
URL: http://ijpcp.iums.ac.ir/article-1-3270-en.html
1- Department of clinical psychology, School of Behavioral Sciences and Health Mental (Psychiatry of Institute Tehran), Iran University of Medical sciences, Iran, Tehran.
2- Department of Psychology Clinical, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
3- Department of Psychology, School of Medicine (Kermanshah Science and Research International Campus), Islamic Azad University, Kermanshah Branch, Kermanshah, Iran.
4- Department of Emergency Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. , mohammadreza.rezaei@kums.ac.ir
Full-Text [PDF 4385 kb]   (3999 Downloads)     |   Abstract (HTML)  (5117 Views)
Full-Text:   (4368 Views)
1. Introduction
oronavirus disease first broke out in Wuhan, China, in December 2019 [1]. Today, most countries globally, including Iran, are thinking of controlling the disease’s spread through social distance and observing health protocols. Still, little attention has been paid to its psychological aspects [678]. Anxiety is considered a common symptom among patients with chronic respiratory disorders and could significantly reduce patients’ quality of life [13]. Regarding coronavirus, anxiety is common among people because it is unknown and undecided [14, 15]. 
Similarly, different tools have been developed to measure chronic respiratory disorders like SARS and MERS in the past. In most cases, anxiety measurement also included physical symptoms due to chronic respiratory diseases and medications’ side effects [13, 20, 21]. It is necessary to create tools to identify anxiety related to this disease and the strategies to prevent it from spreading in the current situation. With the onset of coronavirus, Lee [26] developed a mental health screening tool related to coronavirus. However, considering its limitations, it is necessary to explore its psychological characteristics across the world.
Therefore, a valid and short tool is needed to measure anxiety related to coronavirus due to the increasing anxiety and concern among people because of the impact of this virus on their various functions such as occupation and education. Thus, this study aims to determine the coronavirus anxiety scale’s psychometric characteristics in the Iranian statistical population. 
2. Method
The participants in this study consisted of 399 adults from Kermanshah city who participated online in this study from May 4 to May 7. The authors also obtained the informed consent of participants to take part in this study before filling out demographic information. CAS was conducted based on guidelines needed to standardize instruments in different cultures [33, 34].
Instruments
Coronavirus anxiety scale: this scale includes 5 questions that measure cognitive, behavioral, emotional and physiological dimensions related to coronavirus anxiety during the past two weeks. The questions are scored based on a 5-point Likert scale from 0 (Never) to 4 (Almost every day) [26]. 
The Fear of COVID-19 Scale (FCV-19S): This scale was developed by Kwasi Ahorsu et al. to examine the fear of coronavirus by people. A higher score indicates more fear of coronavirus. Internal consistency and retest reliability were found to be 0.82 and 0.72, respectively [6]. 
Difficulties in Emotion Regulation Scale (DERS): DERS is a self-report tool consisting of 36 materials that measure the normal levels of difficulty in emotion regulation. The whole main scale’s reliability coefficient and the retest reliability were reported to be 0.93 and 0.88, respectively, and the construct and predictive validity were reported to be desirable [35]. This scale was normalized in Iran by Khanzadeh et al. [36]. 
Second version of the Acceptance and Action Questionnaire  (AAQ-II): This questionnaire measures the construct associated with diversity, acceptance, experiential avoidance, and psychological flexibility. Higher scores suggest greater mental flexibility. The mean alpha coefficient was found to be 0.84, and retest reliability, in 3 to 12 months, was found to be 0.81 and 0.79, respectively [37]. This instrument in Iran has appropriate psychometric features [39].
Statistical analysis
Data were analyzed using SPSS software V. 25 and Lisrel software V. 8.8. Descriptive statistics were used to analyze data, and Cronbach’s alpha was used to examine internal consistency. Confirmatory factor analysis was also used to determine to construct validity using Lisrel software V. 8.8.
3. Results
This study was conducted on 399 people with a mean age of 31.57±9.74. Cronbach’s alpha was used to analyze validity. The results of this study suggested that internal consistency using Cronbach’s alpha equals 91.5.
The correlation between the coronavirus anxiety scale and the Fear of COVID-19 Scale, difficulty in emotion regulation questionnaire, and acceptance and action questionnaire were analyzed to determine validity. The correlation between CAS and FCV-19S and the correlation between CAS and the overall score of DERS were found to be 0.45 and 0.27, respectively, which indicates favorable convergence validity of this scale. Moreover, the coronavirus anxiety scale negatively correlates with AAQ-II (r=0.43), suggesting its desirable divergence validity.
Confirmatory factor analysis was used to analyze the validity of the construct. The results of this study indicated that the single-factor model has proper fitting(P= 0.18, df= 2, chi-square = 4.83, RMSEA = 0.04, χ2/df =1.61). Table 1 shows the results of this study.



4. Discussion and Conclusion
CAS showed proper internal consistency, and its Cronbach’s alpha was found to be 91.5. These results are consistent with those of Lee [28], who reported that Cronbach’s alpha for coronavirus anxiety scale is 0.93. The convergence validity results indicated that CAS has a positive and significant correlation with FCV-19S, indicating that those who are more afraid of coronavirus experience more anxieFIty. This finding supports the work of other studies [6, 14, 28]. Also, all of the sub-components of difficulty in emotion regulation(except for difficulties engaging in goal-directed behaviors) had a positive and significant relationship with CAS. The problems of emotion regulation have been identified in many Axis I and Axis II disorders [4344]. Emotional dysregulation has a significant relationship, especially with depression and anxiety disorders [4748]. Thus, it could be argued that those who can hardly regulate their emotions in response to coronavirus disease will experience more anxiety. 
The results of divergence validity also indicated that experiential avoidance had a negative relationship with CAS. The growing body of literature has shown that those with low flexibility reported higher depression and anxiety levels [51, 54]. These findings agree with other studies in this area, analyzing the psychological aspects of coronavirus [55, 56, 57]. The results related to constructing validity also revealed that the single-factor construct has a proper fitting, according to the initial studies [26]. This study had a few limitations, namely convenience sampling and brief analysis by WhatsApp.
Finally, CAS showed proper psychometric characteristics, and health care professionals could use this screening tool to detect coronavirus-related anxiety, which might last for months. 
Ethical Considerations
Compliance with ethical guidelines
This research has been approved in Kermanshah University of Medical Sciences with the code 3010137.
Funding
This article is taken from the Mentor Plan approved by Kermanshah University of Medical Sciences. 
Authors' contributions
Conceptualization: Mohsen mohammadpour, Ali akbar foroughi; Methodology: Mohammad reza Rezaei, Samira moradi; Investigation, sources, preparation, writing-review & editin: Mohsen mohammadpour, Vajiheh Ghorbani; Validation, analysis, Project administration: All authors.
Conflicts of interest
This authors declared no conflict of interest
Acknowledgements
The authors would link to thank the Research and Technology Center of Kermanshah University of Medical Sciences and all health advocates. 

References
  1. Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19). International Journal of Surgery. 2020; 76:71-6. [DOI:10.1016/j.ijsu.2020.02.034] [PMID] [PMCID]
  2. Louie PK, Harada GK, McCarthy MH, Germscheid N, Cheung JPY, Neva MH, et al. The impact of COVID-19 pandemic on spine surgeons worldwide. Global Spine Journal. 2020; 10(5):534-52. [DOI:10.1177/2192568220925783] [PMID] [PMCID]
  3. World Health Organization. Coronavirus Disease (COVID-19) pandemic. Geneva: World Health Organization; 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=EAIaIQobChMI5uq76MDD7gIVeYFQBh2HRA5QEAAYASAAEgJXR_D_BwE
  4. Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. The Lancet Psychiatry. 2020; 7(3):228-9. [DOI:10.1016/S2215-0366(20)30046-8]
  5. Asgari Z, Naghavi A. [Explaining post-traumatic growth: Thematic synthesis of qualitative research (Persian)]. Iranian Journal of Psychiatry and Clinical Psychology. 2019; 25(2):222-34. [DOI:10.32598/ijpcp.25.2.222]
  6. Ahorsu DK, Lin C-Y, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: Development and initial validation. International Journal of Mental Health and Addiction. 2020. [DOI:10.1007/s11469-020-00270-8]
  7. Dong L, Hu S, Gao J. Discovering drugs to treat Coronavirus Disease 2019 (COVID-19). Drug Discoveries & Therapeutics. 2020; 14(1):58-60. [DOI:10.5582/ddt.2020.01012] [PMID]
  8. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-9. [DOI:10.1001/jama.2020.1585] [PMID] [PMCID]
  9. Chong MY, Wang WC, Hsieh WC, Lee CY, Chiu NM, Yeh WC, et al. Psychological impact of severe acute respiratory syndrome on health workers in a tertiary hospital. The British Journal of Psychiatry. 2004; 185(2):127-33. [DOI:10.1192/bjp.185.2.127] [PMID]
  10. Wheaton MG, Abramowitz JS, Berman NC, Fabricant LE, Olatunji BO. Psychological predictors of anxiety in response to the H1N1(swine flu) pandemic. Cognitive Therapy and Research. 2012; 36(3):210-8. [DOI:10.1007/s10608-011-9353-3]
  11. Wu P, Fang Y, Guan Z, Fan B, Kong J, Yao Z, et al. The psychological impact of the SARS epidemic on hospital employees in China: exposure, risk perception, and altruistic acceptance of risk. The Canadian Journal of Psychiatry. 2009; 54(5):302-11. [DOI:10.1177/070674370905400504] [PMID] [PMCID]
  12. Yip PSF, Cheung YT, Chau PH, Law YW. The impact of epidemic outbreak: The case of Severe Acute Respiratory Syndrome (SARS) and suicide among older adults in Hong Kong. Crisis. 2010; 31(2):86-92. [DOI:10.1027/0227-5910/a000015] [PMID]
  13. Dong XY, Wang L, Tao YX, Suo XL, Li YC, Liu F, et al. Psychometric properties of the anxiety inventory for respiratory disease in patients with COPD in China. International Journal of Chronic Obstructive Pulmonary Disease. 2017; 12:49-58. [DOI: 10.2147/COPD.S117626]
  14. Harper CA, Satchell LP, Fido D, Latzman RD. Functional fear predicts public health compliance in the COVID-19 pandemic. International Journal of Mental Health and Addiction. 2020. [DOI:10.1007/s11469-020-00281-5] [PMID] [PMCID]
  15. Banerjee D. The COVID-19 outbreak: Crucial role the psychiatrists can play. Asian Journal of Psychiatry. 2020; 50:102014. [DOI:10.1016/j.ajp.2020.102014] [PMID] [PMCID]
  16. Moghanibashi-Mansourieh A. Assessing the anxiety level of Iranian general population during COVID-19 outbreak. Asian Journal of Psychiatry. 2020; 51:102076. [DOI:10.1016/j.ajp.2020.102076] [PMID] [PMCID]
  17. Bajema KL, Oster AM, McGovern OL, Lindstrom S, Stenger MR, Anderson TC, et al. Persons evaluated for 2019 novel coronavirus—United States, January 2020. MMWR. Morbidity and Mortality Weekly Report. 2020; 69(6):166-70. [DOI:10.15585/mmwr.mm6906e1] [PMID] [PMCID]
  18. Chan JFW, Yip CC-Y, To KKW, Tang THC, Wong SCY, Leung K-H, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-PCR assay validated in vitro and with clinical specimens. Journal of Clinical Microbiology. 2020; 58(5):e00310-20. [DOI:10.1128/JCM.00310-20] [PMID] [PMCID]
  19. Pérez-Fuentes MDC, Molero Jurado MDM, Oropesa Ruiz NF, Martos Martínez Á, Simón Márquez MDM, Herrera-Peco I, et al. Questionnaire on Perception of Threat from COVID-19. Journal of Clinical Medicine. 2020; 9(4):1196. [DOI:10.3390/jcm9041196] [PMID] [PMCID]
  20. Ayora AF, Soler LM, Gasch AC. Análise de dois questionários sobre a qualidade de vida em pacientes com doença pulmonar obstrutiva crônica. Revista Latino-Americana de Enfermagem. 2019; 27:e3148. [DOI:10.1590/1518-8345.2624.3148] [PMID] [PMCID]
  21. Yohannes AM, Willgoss TG, Fatoye FA, Goldbart J. Validity and reliability of the anxiety inventory for respiratory disease scale in patients with copd, in c42. Creating The Evidence: Generating Tools And Developing Methodologies For Pulmonary And Critical Care Research. American Thoracic Society; 2013.
  22. Taylor S. The psychology of pandemics: Preparing for the next global outbreak of infectious disease. United Kingdom: Cambridge Scholars Publishing; 2019. https://www.cambridgescholars.com/product/978-1-5275-3959-4
  23. Kumar A, Somani A. Dealing with Corona virus anxiety and OCD. Asian Journal of Psychiatry. 2020; 51:102053. [DOI:10.1016/j.ajp.2020.102053] [PMID] [PMCID]
  24. Lee SA. How much “Thinking” about COVID-19 is clinically dysfunctional? Brain, Behavior, and Immunity, 2020; 87:97-8. [DOI:10.1016/j.bbi.2020.04.067] [PMID] [PMCID]
  25. Hamza Shuja K, Aqeel M, Jaffar A, Ahmed A. COVID-19 pandemic and impending global mental health implications. Psychiatria Danubina. 2020; 32(1):32-5. [DOI:10.24869/psyd.2020.32] [PMID]
  26. Lee SA. Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety. Death Studies. 2020; 44(7):393-401. [DOI:10.1080/07481187.2020.1748481] [PMID]
  27. Asmundson GJ, Taylor S. Coronaphobia: Fear and the 2019-nCoV outbreak. Journal of Anxiety Disorders. 2020; 70:102196. [DOI:10.1016/j.janxdis.2020.102196] [PMID] [PMCID]
  28. Lee SA. Replication analysis of the Coronavirus Anxiety Scale. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences. 2020; 33. [DOI:10.14744/DAJPNS.2020.00079]
  29. Lee SA, Mathis AA, Jobe MC, Pappalardo EA. Clinically significant fear and anxiety of COVID-19: A psychometric examination of the Coronavirus Anxiety Scale. Psychiatry Research. 2020; 290:113112. [DOI:10.1016/j.psychres.2020.113112] [PMID] [PMCID]
  30. Evren C, Evren B, Dalbudak E, Topcu M, Kutlu N. Measuring anxiety related to COVID-19: A Turkish validation study of the Coronavirus Anxiety Scale. Death Studies. 2020:1-7. [DOI:10.1080/07481187.2020.1774969] [PMID]
  31. Shah R, Goldstein SM. Use of structural equation modeling in operations management research: Looking back and forward. Journal of Operations management. 2006; 24(2):148-69. [DOI:10.1016/j.jom.2005.05.001]
  32. Kline RB. Principles and practice of structural equation modeling. 4th ed.  New York: Guilford publications; 2015. https://www.guilford.com/books/Principles-and-Practice-of-Structural-Equation-Modeling/Rex-Kline/9781462523344
  33. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. Journal of Clinical Epidemiology. 1993; 46(12):1417-32. [DOI:10.1016/0895-4356(93)90142-N]
  34. Gjersing L, Caplehorn JRM, Clausen T. Cross-cultural adaptation of research instruments: language, setting, time and statistical considerations. BMC Medical Research Methodology. 2010; 10:13. [DOI:10.1186/1471-2288-10-13] [PMID] [PMCID]
  35. Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: Development, factor structure, and initial validation of the difficulties in emotion regulation scale. Journal of psychopathology and behavioral assessment. 2004; 26(1):41-54. [DOI:10.1023/B:JOBA.0000007455.08539.94]
  36. Khanzadeh M, Saeediyan M, Hosseinchari M, Edrissi F. [Factor structure and psychometric properties of difficulties in emotional regulation scale(Persian)]. International Journal of Behavioral Sciences. 2012; 6(1):87-96. http://www.behavsci.ir/article_67768_01a5f82ae30d4cbf3dd322fd6618c7eb.pdf
  37. Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, et al. Preliminary psychometric properties of the Acceptance and Action Questionnaire–II: A revised measure of psychological inflexibility and experiential avoidance. Behavior Therapy. 2011; 42(4):676-88. [DOI:10.1016/j.beth.2011.03.007] [PMID]
  38. Kleszcz B, Dudek JE, Białaszek W, Ostaszewski P, Bond F. The psychometric properties of the Polish version of the Acceptance and Action Questionnaire-II(AAQII). Studia Psychologiczne. 2018; 56(1):1-19. http://research.gold.ac.uk/id/eprint/24769/
  39. Abasi E, Fti L, Molodi R, Zarabi H. [Psychometric properties of Persian version of acceptance and action questionnaire-II(Persian)]. Journal Mamagement System 2013; 3(2):65-80. http://jpmm.miau.ac.ir/article_61.html
  40. Tabachnick BG, Fidell LS. Using multivariate statististics. Boston: Allyn and Bacon; 2001. https://books.google.com/books/about/Using_Multivariate_Statistics.html?id=lVtqAAAAMAAJ
  41. Schermelleh-Engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models: Tests of significance and descriptive goodness-of-fit measures. Methods of Psychological Research Online. 2003; 8(2):23-74. https://psycnet.apa.org/record/2003-08119-003
  42. Gross JJ, Jazaieri H. Emotion, emotion regulation, and psychopathology: An affective science perspective. Clinical Psychological Science. 2014; 2(4):387-401. [DOI:10.1177/2167702614536164]
  43. Gross JJ, Muñoz RF. Emotion regulation and mental health. Clinical Psychology: Science and practice. 1995; 2(2):151-64. [DOI:10.1111/j.1468-2850.1995.tb00036.x]
  44. Repetti RL, Taylor SE, Seeman TE. Risky families: Family social environments and the mental and physical health of offspring. Psychological Bulletin. 2002; 128(2):330. [DOI:10.1037/0033-2909.128.2.330] [PMID]
  45. Ochsner KN, Gross JJ. The neural architecture of emotion regulation. Handbook of Emotion Regulation. 2007; 1(1):87-109. [DOI:10.1111/j.1751-9004.2007.00005.x]
  46. Silk JS, Steinberg L, Morris AS. Adolescents’ emotion regulation in daily life: Links to depressive symptoms and problem behavior. Child Development. 2003; 74(6):1869-80. [DOI:10.1046/j.1467-8624.2003.00643.x] [PMID]
  47. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biological psychiatry. 2003; 54(5):515-28. [DOI:10.1016/S0006-3223(03)00171-9]
  48. Mennin DS. Emotion regulation therapy for generalized anxiety disorder. Clinical Psychology & Psychotherapy: An International Journal of Theory & Practice. 2004; 11(1):17-29. [DOI:10.1002/cpp.389]
  49. Mohammadpour M, Ghorbani V, Khoramnia S, Ahmadi SM, Ghvami M, Maleki M. anxiety, self-compassion, gender differences and COVID-19: Predicting self-care behaviors and fear of COVID-19 based on anxiety and self-compassion with an emphasis on gender differences. Iranian Journal of Psychiatry. 2020; 15(3):213. [DOI:10.18502/ijps.v15i3.3813] [PMID] [PMCID]
  50. Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Network Open. 2020; 3(3):e203976. [DOI:10.1001/jamanetworkopen.2020.3976] [PMID] [PMCID]
  51. Tull MT, Gratz KL, Salters K, Roemer L. The role of experiential avoidance in posttraumatic stress symptoms and symptoms of depression, anxiety, and somatization. The Journal of Nervous and Mental Disease. 2004; 192(11):754-761. [DOI:10.1097/01.nmd.0000144694.30121.89] [PMID]
  52. Kashdan TB, Barrios V, Forsyth JP, Steger MF. Experiential avoidance as a generalized psychological vulnerability: Comparisons with coping and emotion regulation strategies. Behaviour Research and Therapy. 2006; 44(9):1301-20. [DOI:10.1016/j.brat.2005.10.003] [PMID]
  53. Kingston J, Clarke S, Remington B. Experiential avoidance and problem behavior: A mediational analysis. Behavior Modification. 2010; 34(2):145-63. [DOI:10.1177/0145445510362575] [PMID]
  54. Sloan DM. Emotion regulation in action: Emotional reactivity in experiential avoidance. Behaviour Research and Therapy. 2004; 42(11):1257-70. [DOI:10.1016/j.brat.2003.08.006] [PMID]
  55. Liu N, Zhang F, Wei C, Jia Y, Shang Z, Sun L, et al. Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: Gender differences matter. Psychiatry Research. 2020; 287:112921. [DOI:10.1016/j.psychres.2020.112921] [PMID] [PMCID]
  56. Li S, Wang Y, Xue J, Zhao N, Zhu T. The impact of COVID-19 epidemic declaration on psychological consequences: A study on active Weibo users. International Journal of Environmental Research and Public Health. 2020; 17(6):2032. [DOI:10.3390/ijerph17062032] [PMID] [PMCID]
  57. Zhang C, Yang L, Liu S, Ma S, Wang Y, Cai Z, et al. Survey of insomnia and related social psychological factors among medical staffs involved with the 2019 novel coronavirus disease outbreak. Frontiers in Psychiatry. 2020; 11:306. [DOI:10.3389/fpsyt.2020.00306] [PMID] [PMCID]
 
Type of Study: Original Research | Subject: Psychiatry and Psychology
Received: 2020/06/19 | Accepted: 2020/10/27 | Published: 2020/07/31

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Psychiatry and Clinical Psychology

Designed & Developed by : Yektaweb